You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

Claims for Patent: 7,348,009


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,348,009
Title:Recombinant allergen with reduced enzymatic activity
Abstract: The present invention provides a novel treatment for allergy comprising a recombinant allergen with reduced enzymatic activity, thereby reducing the potential for an allergic response upon contact with a wild-type allergen.
Inventor(s): Bruck; Claudine (Rixensart, BE), Bollen; Alex (Itterbeek, BE), Jacobs; Paul (Lanquesaint, BE), Massaer; Marc Georges Francis (Braine le Chateau, BE)
Assignee: SmithKline Beecham Biologicals, s.a. (Rixensart, BE)
Application Number:09/554,860
Patent Claims:1. A recombinant mutant pro-DerP1 allergen of the DerP1 pre-pro-protein of SEQ ID NO: 1 wherein SEQ ID NO: 1 comprises a cysteine to alanine substitution at amino acid position 132 and wherein said pro-DerP1 allergen is from Dermatophagoides pteronyssinus.

2. A therapeutic formulation comprising the recombinant mutant pro-DerP1 allergen as claimed in claim 1 and an adjuvant.

3. The therapeutic formulation as claimed in claim 2, wherein the adjuvant is a preferential stimulator of the Th1-type immune response.

4. The therapeutic formulation as claimed in claim 2, wherein the adjuvant comprises at least one selected from the group consisting of QS21 and 3-O-deacylated monophosphoryl lipid A.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.